Hillhurst Biopharmaceuticals, Inc.
Unlocking the potential of therapeutic gasses through novel liquid medicines
General Information
Get notified when Hillhurst Biopharmaceuticals, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Hillhurst Biopharmaceuticals, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Hillhurst Biopharmaceuticals, Inc.
Taxonomy: therapeutic gases, GLASS platform, liquid medicines, sickle cell disease, Parkinson's disease, acute pain, carbon monoxide therapy, cellular metabolic system, heme oxygenase, inflammatory processes, cell death prevention, hemoglobin polymerization, novel liquid therapeutics, dosing technology, pharmaceutical innovation
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 1 | •••• •••• | 20 Dec 2023 |
| Grant | •••••• | 1 | •••• •••• | 07 Nov 2023 |
| Grant | •••••• | 1 |
|
20 Sep 2023 |
Hillhurst Biopharmaceuticals, Inc. Alternatives & Competitors
Targeting the microbiome to improve human health
Targeting treatment for Alzheimer's Disease, Major Depressive Disorder, Bipolar Disorder, and PTSD.
Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and epigenetic i...
FAQ About Hillhurst Biopharmaceuticals, Inc.
Don't just browse. Track.
Signal Tracker monitors Hillhurst Biopharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
